Filtered By:
Therapy: Cardiac Resynchronization Therapy

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 65 results found since Jan 2013.

Cardiology MCQ 313: Predictors of response to CRT
Predictors of response to CRT from the MADIT-CRT trial a) Nonischemic origin b) Left bundle-branch block c) QRS duration of 150 milliseconds or more d) All of the above ["Click here for the answer with explanation", "Correct Answer:"] d) All of the above Predictors of response to CRT in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) [Circulation. 2011; 124: 1527-1536] were: female sex, nonischemic origin, left bundle-branch block, QRS duration of 150 milliseconds or more, prior hospitalization for heart failure, left ventricular end-diastolic volume of 12...
Source: Cardiophile MD - September 18, 2014 Category: Cardiology Authors: Prof. Dr. Johnson Francis MD, DM, FACC, FRCP Edin, FRCP London Tags: Cardiology MCQ DM / DNB Cardiology Entrance ECG / Electrophysiology Source Type: blogs

MADIT-CRT Long-Term Follow-Up Shows Survival Benefit with CRT-D
MADIT-CRT was an influential trial that showed a reduction in heart failure complications — but not mortality — when cardiac resynchronization therapy (CRT) was added to an implantable defibrillator in patients with mild heart failure who also had left bundle-branch block (LBBB). Patients in the trial were followed for 2.4 years, raising questions about the long-term effects of CRT. Now, a second look at 854 patients who participated in a follow-up study, presented at the American College of Cardiology and published in the New England Journal of Medicine, suggests that over the long term, CRT More…
Source: CardioBrief - March 30, 2014 Category: Cardiology Authors: Larry Husten Tags: Heart Failure Heart Rhythms CRT ICD MADIT resynchronization Source Type: blogs

New SJM Optisure Defibrillation Lead Has Extra Insulation
St. Jude Medical, having received approval in U.S., Europe, and other markets, is releasing its new high-voltage Optisure defibrillation lead. The device is based on the company’s Durata lead, but with extra insulation at the proximal end of th...
Source: Medgadget - March 25, 2014 Category: Technology Consultants Authors: Editors Tags: Cardiac Surgery Cardiology Radiology Source Type: blogs

Three New Pacemakers from SJM, Including a Quadripolar, Approved in U.S.
St. Jude Medical received FDA approval for its Allure Quadra cardiac resynchronization therapy pacemaker (CRT-P), as well as for the Assurity and Endurity pacemakers. The Allure Quadra is the first pacemaker approved in the U.S. that provides quadrip...
Source: Medgadget - March 24, 2014 Category: Technology Consultants Authors: Editors Tags: Cardiac Surgery Cardiology Source Type: blogs

BIOTRONIK Sentus ProMRI, World’s Smallest MR Conditional Leads CE Marked
BIOTRONIK recently received the European CE Mark and is now releasing its Sentus ProMRI bipolar cardiac resynchronization therapy (CRT) leads. With a diameter of only 1.6 mm, these are the narrowest MR compatible leads available. Since people on card...
Source: Medgadget - March 6, 2014 Category: Technology Consultants Authors: Editors Tags: Cardiology Radiology Source Type: blogs

Cied
CIED: Cardiovascular Implantable Electronic Device Examples of CIED: Pacemaker Implantable cardioverter-defibrillator (ICD) Heart failure device (CRT: Cardiac Resynchronization Therapy; also known as CRT-P) Combo device of CRT with ICD: CRT-D Implantable loop recorder (ILR)
Source: Cardiophile MD - December 26, 2013 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Cardiovascular Implantable Electronic Device Source Type: blogs

BIOTRONIK Announces Idova 7 High Energy ICDs and CRT-Ds with MR Compatibility
BIOTRONIK has released its Idova 7 series of ICDs (implantable cardioverter-defibrillators) and CRT-Ds (cardiac resynchronization therapy defibrillators), the only devices with a 45 joule energy delivery that are also MR compatible. The defibrillator...
Source: Medgadget - October 10, 2013 Category: Technology Consultants Authors: Editors Tags: Cardiology Critical Care Source Type: blogs

Biotronik Releases Ilesto DX ICD/CRT-D in US
Having received FDA approval for the Ilesto family of implantable cardioverter-defibrillator (ICD) / cardiac resynchronization therapy defibrillator (CRT-D) devices, BIOTRONIK is launching the Ilesto DX platform in the US. Currently, there are two ba...
Source: Medgadget - October 7, 2013 Category: Technology Consultants Authors: Nishey Wanchoo Tags: Cardiac Surgery Cardiology Source Type: blogs

Study Fails To Support Broader Patient Population For Cardiac-Resynchronization Therapy
Cardiac-resynchronization therapy (CRT) has been shown to be beneficial in heart failure (HF) patients with a wide QRS interval. These benefits have not been reproduced so far in patients with narrow QRS intervals, though many such patients have ventricular dyssynchrony. Now a new study, presented at the European Society of Cardiology in Amsterdam and published simultaneously in the New England Journal of Medicine, once again has failed to find benefits for CRT in a broader patient population. The EchoCRT Study Group randomized HF patients with a QRS duration < 130 msec and left ventricular dyssnchrony upon echocardiography. More…
Source: CardioBrief - September 3, 2013 Category: Cardiology Authors: Larry Husten Tags: Heart Failure Heart Rhythms Amsterdam CRT European Society of Cardiology QRS complex Source Type: blogs

Day 3 ESC2013 — Longevity of Tour de France cyclists, meeting old friends, social media, and big plans.
A general rule about writing a story is to lead with the important stuff. I’ve reviewed each of my ESC2013 updates, and as it turns out, each day I have led with the folly. Sorry about that. I’m going to continue the trend. If you had a blog, you could do this too. Before I’m done, I’ll tell you about some of the serious work that accomplished today. First the fun. View from the 4th floor lobby You have to know about the morning here at the eco-friendly Amadi Park Hotel. It’s an amazing place, situated in a beautiful neighborhood.  On the website, they claim to serve a very tasty and honest D...
Source: Dr John M - September 3, 2013 Category: Cardiology Authors: Dr John Source Type: blogs

Observational Study Lends Support to CRT Guidelines
A large observational study published in JAMA suggests that patients with left bundle-branch block (LBBB) and longer QRS duration derive the most benefit from a cardiac resynchronization therapy defibrillator (CRT-D). The findings appear to support current, but often criticized, guidelines from the American College of Cardiology, American Heart Association, and the Heart Rhythm Society, in which a class I recommendation is restricted to patients with LBBB and QRS duration of 150 ms or greater. Click here to read the full post on Forbes.      
Source: CardioBrief - August 13, 2013 Category: Cardiology Authors: Larry Husten Tags: Heart Rhythms American College of Cardiology american heart association CRT-D guidelines Heart Rhythm Society JAMA Left bundle branch block Observational study pacemakers QRS complex Source Type: blogs

Boston Scientific’s New Pacemakers Monitor Breathing to Adjust Pacing
Boston Scientific is releasing in Europe three new cardiac pacemakers featuring RightRate technology that monitors the patient’s breathing to help adjust the pulses delivered to the heart. The lineup comprises an INLIVEN cardiac resynchronizati...
Source: Medgadget - June 26, 2013 Category: Technology Consultants Authors: Editors Tags: Cardiology Radiology Source Type: blogs

St. Jude’s Quadra Assura MP with MultiPoint Pacing Gets European Go Ahead
St. Jude Medical won the European CE Mark for its Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D). Like the previously released Quadra Assura, the MP model takes advantage of four electrodes in the compatible Quartet Lead for...
Source: Medgadget - June 24, 2013 Category: Technology Consultants Authors: Editors Tags: Cardiac Surgery Cardiology Radiology Source Type: blogs

BIOTRONIK’s Releases MRI Compatible Ilesto 7 ICD/CRT-D’s
Having recently obtained both FDA clearance and CE Mark, BIOTRONIK is bringing to market its Ilesto 7 cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D) devices. These are the world’s first MRI compatible dev...
Source: Medgadget - June 20, 2013 Category: Technology Consultants Authors: Editors Tags: Cardiac Surgery Cardiology Radiology Source Type: blogs

St. Jude Medical’s High Voltage ICD/CRT-Ds Approved in U.S.
St. Jude Medical won FDA approval for the new Ellipse and Assura lines of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). These devices are capable of creating more powerful electric shock...
Source: Medgadget - June 17, 2013 Category: Technology Consultants Authors: Editors Tags: Cardiac Surgery Cardiology Radiology Source Type: blogs